Bioconjugated quantum dots for cancer research: present status, prospects and remaining issues

Area of Science:

• Nanotechnology
• Biomedical Engineering
• Materials Science

Background:

• Semiconductor quantum dots (QDs) exhibit quantum confinement, enabling tunable optical properties and bright, stable photoluminescence (PL).
• QDs are promising for biomedical imaging and therapy due to their unique characteristics.
• Current photodynamic therapy (PDT) for cancer faces limitations due to the lack of suitable photostable, near-infrared (NIR) fluorophores and photosensitizing drugs.

Purpose of the Study:

• To review the potential of semiconductor quantum dots (QDs) for cancer imaging and photodynamic therapy (PDT).
• To highlight advancements in QD synthesis, targeting, and application in cancer research.

Main Methods:

• Review of synthesis methods for visible and NIR QDs.
• Discussion of QD strategies for targeting cancer cells.
• Analysis of QD applications in in vitro and in vivo cancer imaging.
• Examination of QD-photosensitizer (PS) conjugates for PDT.
• Evaluation of QD-based multimodality imaging and therapy.

Main Results:

• Biocompatible and NIR QDs have opened new avenues for cancer fluorescence imaging and PDT.
• QD-PS conjugates facilitate energy transfer for photosensitized production of reactive oxygen intermediates (ROI).
• QDs demonstrate potential for enhanced cancer cell targeting and imaging.

Conclusions:

• Quantum dots represent a significant advancement in developing effective tools for cancer imaging and photodynamic therapy.
• Further research is needed to address remaining challenges in QD probe development for clinical translation.